Comparison 1.
Second trimester amniocentesis versus control
| Outcome or subgroup title | No. of studies | No. of participants | Statistical method | Effect size |
|---|---|---|---|---|
| 1 Not complied with allocated procedure | 1 | 4606 | Risk Ratio (M-H, Fixed, 95% CI) | 1.73 [1.03, 2.91] |
| 3 Multiple insertions | 1 | 4606 | Risk Ratio (M-H, Fixed, 95% CI) | 91.08 [5.61, 1477. 53] |
| 4 Second test performed | 1 | 4606 | Risk Ratio (M-H, Fixed, 95% CI) | 41.04 [2.48, 678.07] |
| 5 Laboratory failure | 1 | 4606 | Risk Ratio (M-H, Fixed, 95% CI) | 27.02 [1.61, 454.31] |
| 6 All non-mosaic abnormalities | 1 | 4593 | Risk Ratio (M-H, Fixed, 95% CI) | 30.85 [1.85, 515.31] |
| 13 Vaginal bleeding after test | 1 | 4606 | Risk Ratio (M-H, Fixed, 95% CI) | 0.95 [0.66, 1.37] |
| 14 Amniotic leakage after test | 1 | 4606 | Risk Ratio (M-H, Fixed, 95% CI) | 3.90 [1.95, 7.80] |
| 20 All known pregnancy loss (including termination of pregnancy) | 1 | 4606 | Risk Ratio (M-H, Fixed, 95% CI) | 1.41 [0.99, 2.00] |
| 21 Termination of pregnancy (all) | 1 | 4606 | Risk Ratio (M-H, Fixed, 95% CI) | 2.50 [0.97, 6.44] |
| 24 Spontaneous miscarriage | 1 | 4606 | Risk Ratio (M-H, Fixed, 95% CI) | 1.60 [1.02, 2.52] |
| 26 Perinatal deaths | 1 | 4606 | Risk Ratio (M-H, Fixed, 95% CI) | 0.63 [0.28, 1.38] |
| 27 Stillbirths | 1 | 4606 | Risk Ratio (M-H, Fixed, 95% CI) | 0.83 [0.36, 1.93] |
| 28 Neonatal deaths | 1 | 4606 | Risk Ratio (M-H, Fixed, 95% CI) | 0.11 [0.01, 2.06] |
| 29 All recorded deaths after viability | 1 | 4606 | Risk Ratio (M-H, Fixed, 95% CI) | 0.63 [0.28, 1.38] |
| 30 Anomalies (all recorded) | 1 | 4507 | Risk Ratio (M-H, Fixed, 95% CI) | 0.93 [0.62, 1.39] |
| 31 Talipes | 1 | 4507 | Risk Ratio (M-H, Fixed, 95% CI) | 0.68 [0.37, 1.22] |
| 35 Neonatal respiratory distress syndrome | 1 | 4507 | Risk Ratio (M-H, Fixed, 95% CI) | 2.11 [1.06, 4.19] |